Related Experiment Video
Updated: Aug 6, 2026
05:40
Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Published on: December 22, 2023
Prelabor rupture of membranes at term: induction techniques
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA. mozurk@med.umich.edu
Clinical Obstetrics and Gynecology
|August 4, 2006
Summary
Clinical management for term premature rupture of membranes (PROM) remains controversial. Studies show no significant benefits of immediate vs. delayed induction or misoprostol over oxytocin for infection or cesarean rates.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
Background:
- Management of term premature rupture of membranes (PROM) involves expectant management or labor induction.
- Induction agents include oxytocin, dinoprostone (PGE2), and misoprostol.
- Clinical outcomes and risks associated with different management strategies are debated.
Purpose of the Study:
- To review and compare the efficacy and safety of various management options for PROM at term.
- To evaluate the impact of immediate versus delayed induction on maternal and neonatal outcomes.
- To assess the role of different induction agents, including misoprostol, in managing term PROM.
Main Methods:
- Review of clinical management options: expectant management, oxytocin, dinoprostone (PGE2), and misoprostol.
- Analysis of findings from early studies and the definitive TermPROM study.
- Comparison of randomized trials evaluating misoprostol versus other agents for term PROM.
Main Results:
- Early studies suggested oxytocin induction might reduce infections but increase cesarean risk.
- The TermPROM study found no difference in neonatal infections between immediate and delayed induction with oxytocin and PGE2.
- Neither PGE2 nor delayed induction reduced cesarean sections compared to immediate oxytocin; misoprostol showed no significant advantage.
Conclusions:
- Clinical management of term PROM lacks a universally superior strategy.
- Current evidence does not support significant advantages of misoprostol or delayed induction over immediate oxytocin for term PROM.
- Further research may be needed to clarify optimal management protocols for term PROM.